Concepts (210)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chondrocytes | 13 | 2020 | 155 | 1.960 |
Why?
|
| SOX9 Transcription Factor | 7 | 2016 | 13 | 1.710 |
Why?
|
| Nucleus Pulposus | 2 | 2016 | 7 | 1.050 |
Why?
|
| Protein Kinase C | 13 | 2003 | 52 | 0.790 |
Why?
|
| Mitogen-Activated Protein Kinases | 13 | 2003 | 33 | 0.790 |
Why?
|
| Gene Expression Regulation | 4 | 2020 | 281 | 0.670 |
Why?
|
| Annulus Fibrosus | 2 | 2017 | 5 | 0.660 |
Why?
|
| Animals | 26 | 2023 | 3780 | 0.610 |
Why?
|
| Cells, Cultured | 15 | 2020 | 539 | 0.580 |
Why?
|
| Cell Differentiation | 8 | 2016 | 135 | 0.580 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2014 | 46 | 0.550 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2016 | 1 | 0.540 |
Why?
|
| Growth Plate | 1 | 2016 | 15 | 0.530 |
Why?
|
| Pyridines | 2 | 2016 | 36 | 0.520 |
Why?
|
| rho-Associated Kinases | 1 | 2016 | 5 | 0.520 |
Why?
|
| Signal Transduction | 13 | 2020 | 447 | 0.520 |
Why?
|
| Collagen Type II | 4 | 2016 | 20 | 0.520 |
Why?
|
| Amides | 1 | 2016 | 16 | 0.520 |
Why?
|
| Chondrogenesis | 5 | 2003 | 29 | 0.470 |
Why?
|
| Isoenzymes | 8 | 2002 | 53 | 0.430 |
Why?
|
| Mesoderm | 8 | 2003 | 19 | 0.420 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 6 | 2000 | 14 | 0.370 |
Why?
|
| Cartilage, Articular | 5 | 2020 | 420 | 0.370 |
Why?
|
| Apoptosis | 5 | 2003 | 205 | 0.360 |
Why?
|
| Genome | 1 | 2010 | 9 | 0.350 |
Why?
|
| Rats | 4 | 2016 | 678 | 0.340 |
Why?
|
| Binding Sites | 3 | 2016 | 75 | 0.330 |
Why?
|
| Mice, Knockout | 5 | 2020 | 316 | 0.330 |
Why?
|
| Mice | 10 | 2023 | 1461 | 0.310 |
Why?
|
| Intervertebral Disc Degeneration | 2 | 2022 | 79 | 0.280 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 7 | 2003 | 16 | 0.280 |
Why?
|
| Cartilage | 6 | 2010 | 102 | 0.260 |
Why?
|
| Enzyme Inhibitors | 8 | 2016 | 120 | 0.260 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 11 | 2003 | 22 | 0.230 |
Why?
|
| Intervertebral Disc | 2 | 2016 | 123 | 0.230 |
Why?
|
| Osteoarthritis | 2 | 2020 | 328 | 0.230 |
Why?
|
| Nitric Oxide | 5 | 2003 | 81 | 0.230 |
Why?
|
| Endothelial Cells | 1 | 2023 | 61 | 0.210 |
Why?
|
| Musculoskeletal Diseases | 1 | 2023 | 46 | 0.210 |
Why?
|
| Bone Regeneration | 1 | 2023 | 74 | 0.210 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2003 | 59 | 0.210 |
Why?
|
| Enzyme Activation | 9 | 2003 | 120 | 0.200 |
Why?
|
| Chick Embryo | 8 | 2003 | 15 | 0.200 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 8 | 2003 | 36 | 0.200 |
Why?
|
| Microbiota | 1 | 2023 | 104 | 0.200 |
Why?
|
| Caspases | 5 | 2003 | 26 | 0.200 |
Why?
|
| Macrophages | 2 | 1999 | 108 | 0.190 |
Why?
|
| Awards and Prizes | 1 | 2022 | 21 | 0.190 |
Why?
|
| Gene Expression Profiling | 2 | 2014 | 138 | 0.190 |
Why?
|
| Sirolimus | 1 | 2001 | 20 | 0.190 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2023 | 181 | 0.180 |
Why?
|
| Intervertebral Disc Displacement | 1 | 2022 | 87 | 0.180 |
Why?
|
| Malocclusion | 1 | 2020 | 1 | 0.180 |
Why?
|
| Temporomandibular Joint Disorders | 1 | 2020 | 9 | 0.180 |
Why?
|
| Osteogenesis | 2 | 2023 | 110 | 0.180 |
Why?
|
| Low Back Pain | 1 | 2022 | 110 | 0.170 |
Why?
|
| Immunosuppressive Agents | 1 | 2001 | 140 | 0.170 |
Why?
|
| Receptors, Vitronectin | 1 | 2000 | 5 | 0.170 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2020 | 13 | 0.170 |
Why?
|
| Metformin | 1 | 2020 | 20 | 0.170 |
Why?
|
| Receptors, Laminin | 1 | 1999 | 1 | 0.170 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2016 | 8 | 0.160 |
Why?
|
| Up-Regulation | 1 | 2020 | 177 | 0.160 |
Why?
|
| Menisci, Tibial | 2 | 2020 | 177 | 0.160 |
Why?
|
| Cell Proliferation | 2 | 2016 | 178 | 0.150 |
Why?
|
| Base Sequence | 2 | 2016 | 107 | 0.140 |
Why?
|
| Gene Expression | 2 | 2017 | 202 | 0.140 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2017 | 35 | 0.140 |
Why?
|
| Receptors, CCR5 | 1 | 2017 | 14 | 0.140 |
Why?
|
| Introns | 1 | 2016 | 16 | 0.140 |
Why?
|
| Sternum | 1 | 2016 | 4 | 0.130 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2016 | 9 | 0.130 |
Why?
|
| Cell Movement | 1 | 2017 | 82 | 0.130 |
Why?
|
| Gene Deletion | 1 | 2016 | 42 | 0.130 |
Why?
|
| Extremities | 1 | 2016 | 28 | 0.130 |
Why?
|
| Osteoblasts | 1 | 2016 | 55 | 0.130 |
Why?
|
| Cell Line, Transformed | 1 | 2016 | 16 | 0.130 |
Why?
|
| Promoter Regions, Genetic | 1 | 2016 | 96 | 0.130 |
Why?
|
| Interleukin-1 | 2 | 2014 | 49 | 0.130 |
Why?
|
| Protein Binding | 2 | 2014 | 132 | 0.130 |
Why?
|
| Bone and Bones | 2 | 2023 | 118 | 0.130 |
Why?
|
| RNA, Messenger | 1 | 2016 | 308 | 0.120 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2016 | 341 | 0.120 |
Why?
|
| Cadherins | 4 | 2003 | 36 | 0.120 |
Why?
|
| Position-Specific Scoring Matrices | 1 | 2014 | 1 | 0.120 |
Why?
|
| Nucleotide Motifs | 1 | 2014 | 2 | 0.120 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2014 | 21 | 0.120 |
Why?
|
| Protein Transport | 1 | 2014 | 32 | 0.120 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2014 | 47 | 0.120 |
Why?
|
| Trans-Activators | 3 | 2003 | 25 | 0.110 |
Why?
|
| MicroRNAs | 1 | 2014 | 54 | 0.110 |
Why?
|
| Cell Line | 3 | 2010 | 280 | 0.110 |
Why?
|
| Humans | 10 | 2023 | 28436 | 0.110 |
Why?
|
| Blotting, Western | 3 | 2003 | 148 | 0.110 |
Why?
|
| Down-Regulation | 4 | 2016 | 102 | 0.110 |
Why?
|
| Inflammation | 1 | 2014 | 284 | 0.100 |
Why?
|
| Cell Division | 3 | 2001 | 83 | 0.100 |
Why?
|
| Caspase 3 | 5 | 2003 | 20 | 0.100 |
Why?
|
| Fibronectins | 3 | 2000 | 21 | 0.100 |
Why?
|
| Cell Adhesion | 3 | 2000 | 32 | 0.100 |
Why?
|
| Protein Kinase C-alpha | 5 | 2002 | 8 | 0.090 |
Why?
|
| Limb Buds | 2 | 2009 | 2 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2003 | 351 | 0.090 |
Why?
|
| Rabbits | 4 | 2003 | 185 | 0.090 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2010 | 5 | 0.090 |
Why?
|
| Transcriptional Activation | 1 | 2010 | 32 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 57 | 0.090 |
Why?
|
| Gene Regulatory Networks | 1 | 2010 | 29 | 0.090 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2000 | 34 | 0.080 |
Why?
|
| Integrins | 2 | 2000 | 14 | 0.080 |
Why?
|
| Body Patterning | 1 | 2009 | 3 | 0.080 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2009 | 71 | 0.080 |
Why?
|
| Cytoskeletal Proteins | 3 | 2003 | 18 | 0.080 |
Why?
|
| Disease Models, Animal | 2 | 2020 | 619 | 0.070 |
Why?
|
| Phosphorylation | 3 | 2001 | 149 | 0.070 |
Why?
|
| Collagen | 3 | 2003 | 82 | 0.070 |
Why?
|
| Immunohistochemistry | 2 | 2014 | 362 | 0.070 |
Why?
|
| Matrix Metalloproteinase 13 | 2 | 2017 | 27 | 0.060 |
Why?
|
| Disease Progression | 2 | 2020 | 717 | 0.060 |
Why?
|
| Flavonoids | 5 | 2003 | 17 | 0.060 |
Why?
|
| Tretinoin | 1 | 2003 | 15 | 0.050 |
Why?
|
| Protein Kinases | 1 | 2003 | 13 | 0.050 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2003 | 42 | 0.050 |
Why?
|
| Oxygen | 1 | 2023 | 73 | 0.050 |
Why?
|
| Gastrointestinal Tract | 1 | 2023 | 53 | 0.050 |
Why?
|
| Bacteria | 1 | 2023 | 74 | 0.050 |
Why?
|
| Bone Marrow | 1 | 2023 | 79 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2017 | 225 | 0.050 |
Why?
|
| Cell Adhesion Molecules | 2 | 2000 | 20 | 0.050 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 1999 | 40 | 0.050 |
Why?
|
| NF-kappa B | 1 | 2003 | 118 | 0.050 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2001 | 1 | 0.050 |
Why?
|
| Cell Culture Techniques | 1 | 2001 | 32 | 0.050 |
Why?
|
| Carbazoles | 1 | 2000 | 6 | 0.040 |
Why?
|
| Facial Pain | 1 | 2020 | 7 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2001 | 82 | 0.040 |
Why?
|
| Nociception | 1 | 2020 | 10 | 0.040 |
Why?
|
| Sulfonamides | 1 | 2000 | 41 | 0.040 |
Why?
|
| Temporomandibular Joint | 1 | 2020 | 18 | 0.040 |
Why?
|
| Mice, Obese | 1 | 2020 | 6 | 0.040 |
Why?
|
| Cell Fractionation | 1 | 2000 | 5 | 0.040 |
Why?
|
| Epidermal Growth Factor | 1 | 2000 | 28 | 0.040 |
Why?
|
| Integrin alpha6beta1 | 1 | 1999 | 1 | 0.040 |
Why?
|
| Hypoglycemic Agents | 1 | 2020 | 40 | 0.040 |
Why?
|
| Laminin | 1 | 1999 | 7 | 0.040 |
Why?
|
| Protein Kinase C-delta | 1 | 1999 | 10 | 0.040 |
Why?
|
| Random Allocation | 1 | 2020 | 129 | 0.040 |
Why?
|
| Proteoglycans | 2 | 2014 | 132 | 0.040 |
Why?
|
| Time Factors | 2 | 2001 | 1491 | 0.040 |
Why?
|
| Receptors, Muscarinic | 1 | 1999 | 4 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 517 | 0.040 |
Why?
|
| beta Catenin | 3 | 2003 | 65 | 0.040 |
Why?
|
| Child | 1 | 2022 | 1420 | 0.040 |
Why?
|
| Nitroprusside | 3 | 2002 | 6 | 0.030 |
Why?
|
| Aggrecans | 1 | 2017 | 54 | 0.030 |
Why?
|
| SOXD Transcription Factors | 1 | 2016 | 1 | 0.030 |
Why?
|
| Lumbar Vertebrae | 1 | 2022 | 384 | 0.030 |
Why?
|
| X-Ray Microtomography | 1 | 2017 | 82 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2022 | 1143 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2016 | 106 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2009 | 37 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2016 | 249 | 0.030 |
Why?
|
| Cytokines | 1 | 2017 | 230 | 0.030 |
Why?
|
| Risk Factors | 1 | 2022 | 2408 | 0.030 |
Why?
|
| ADAMTS5 Protein | 1 | 2014 | 19 | 0.030 |
Why?
|
| Cattle | 1 | 2014 | 127 | 0.030 |
Why?
|
| Transfection | 1 | 2014 | 121 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2014 | 51 | 0.030 |
Why?
|
| ADAM Proteins | 1 | 2014 | 41 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2014 | 176 | 0.030 |
Why?
|
| Homeostasis | 1 | 2014 | 67 | 0.030 |
Why?
|
| alpha Catenin | 2 | 2003 | 2 | 0.030 |
Why?
|
| Nitric Oxide Donors | 2 | 2002 | 7 | 0.020 |
Why?
|
| Phenotype | 2 | 2002 | 313 | 0.020 |
Why?
|
| Caspase Inhibitors | 2 | 2001 | 5 | 0.020 |
Why?
|
| Dimerization | 1 | 2010 | 21 | 0.020 |
Why?
|
| Chromatin | 1 | 2010 | 17 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2010 | 60 | 0.020 |
Why?
|
| DNA | 1 | 2010 | 104 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2010 | 213 | 0.020 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 2 | 1999 | 15 | 0.020 |
Why?
|
| Mutation | 1 | 2010 | 353 | 0.020 |
Why?
|
| Male | 1 | 2022 | 15291 | 0.020 |
Why?
|
| Female | 1 | 2022 | 15730 | 0.010 |
Why?
|
| Cytochalasin D | 1 | 2003 | 5 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2002 | 9 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2002 | 23 | 0.010 |
Why?
|
| Hydrolysis | 1 | 2002 | 7 | 0.010 |
Why?
|
| DNA Primers | 1 | 2002 | 50 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2002 | 160 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2001 | 21 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2001 | 34 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2001 | 116 | 0.010 |
Why?
|
| Imidazoles | 1 | 2001 | 55 | 0.010 |
Why?
|
| Embryonic Induction | 1 | 2000 | 1 | 0.010 |
Why?
|
| Receptors, Fibronectin | 1 | 2000 | 1 | 0.010 |
Why?
|
| Isoquinolines | 1 | 2000 | 12 | 0.010 |
Why?
|
| Pyrroles | 1 | 2000 | 24 | 0.010 |
Why?
|
| Indoles | 1 | 2000 | 38 | 0.010 |
Why?
|
| Models, Biological | 1 | 2001 | 326 | 0.010 |
Why?
|
| Bucladesine | 1 | 1999 | 2 | 0.010 |
Why?
|
| Mitogens | 1 | 1999 | 5 | 0.010 |
Why?
|
| HL-60 Cells | 1 | 1999 | 14 | 0.010 |
Why?
|
| Receptor, Muscarinic M3 | 1 | 1999 | 1 | 0.010 |
Why?
|
| Carbachol | 1 | 1999 | 4 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 1999 | 6 | 0.010 |
Why?
|
| Protein Kinase C-epsilon | 1 | 1999 | 2 | 0.010 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 1999 | 21 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1999 | 119 | 0.010 |
Why?
|
| Culture Techniques | 1 | 1998 | 17 | 0.010 |
Why?
|